It has been reported that humanurine showedweak blood group Lewis activity (Lea) using the anti-Lea antibody of humanserum.1>2) In the previous paper,3} it was also demonstrated that Lea-and Leb-active substances were present in normal humanurine of nonsecretors and secretors using anti-Lea and anti-Leb immunesera.4) The active substances were then partially purified from the urine of two donors.3>5) This paper aims to clarify the chemical characterization of the isolated Lewis-active substances, especially with respect to carbohydrate analysis of the determinant groups. Four different crude urinary fractions3) of blood group O-secretors (7-SY, 9-HM), O-nonsecretor (3-HO), and A-nonsecretor (5-HT) were used in this experiment. Purification was achieved initially by membraneultra filtration, with a DEAE-Sephadex (A-25, Pharmacia Fine Chem.) column (3 x 45 cm) using an acetate-pyridine buffer system at pH5.7, and subsequently by gel filtration on a Bio-Gel (P-6, Bio-Rad Lab.) column (2.5x70cm), as previously reported.3>5) The homogeneity of the finally purified fraction, P-l in each case, was examined by rechromatography on a Bio-Gel (P-10) column (1.5 x 110cm) with elution by 0.15m NH4COOH.The mean molecular weight (Mr) was determined by this gel filtration, utilizing an FITC-dextran kit (Pharmacia Fine Chem.) as a standard molecular marker. Amino acid analysis was performed with an automatic amino acid analyzer (Atto-MLC-703 type). Prior to the determination, each sample (0.5~1 mg) was hydrolyzed at 1 10°C for 23hr in 2ml of6n HC1 (Sp. grade, Wako Chem.) with sealing. After hydrolysis, the hydrochloric acid was removed by evaporation and the resultant residue was subjected to the analysis. The rechromatographed fractions, P-l in each case, were submitted to mild alkaline degradation according to the method6) with a slight modification as follows: A small amount of the sample (2~5mg) was treated with 1 m NaBH4 containing 0.05m NaOH(2~5ml) in a screw-capped vial at 50°C for 16hr.
After the reaction, the excess of NaBH4was removed by evaporation, the repetative addition of methanol and acidifying by 2m acetic acid. The residue was again dissolved in a small amount of water and passed through a Dowex 50-X2 column (1.5 x 12cm, H+-form, 100-200 mesh) with elution by water. The eluting solution was monitored with an assay of neutral sugar by the phenolH2SO4method.7) The neutral fraction was pooled, concentrated with an evaporator, and then passed through a Bio-Gel (P-2) column (1 x 60cm). The main peak excluded from the gels was pooled and rechromatographed on the Bio-Gel (P-10) column as described above. The Mr of these four samples (P-l-A) was also determined with this column using 0.15m NH4COOH as the eluent solution. Assays for blood group Lewis activity were achieved by the hemagglutinination inhibition (HAI) test with twofold serial antigen dilutions as previously described.3) A carbohydrate analysis of the fractions P-l and P-l-A was gas chromatographically achieved according to the previous method,8) after a sample (0.5~1 mg) was hydrolyzed with 2.5 n trifluoroacetic acid (TFA) for 8 hr at 100°C with sealing. As partly reported in the previous paper,3) the Leaor Leb-active substance was highly concentrated in the D-l fraction on the DEAE-Sephadex column (A-25), and subsequently located in the P-l fraction on the Bio-Gel (P-6) column in either case for the four samples. The P-l and P-l-A fractions rechromatographedon the same column of Bio-Gel (P-10) exhibited similar HAI activity. The minimumconcentration of HAI was 1~4 /zg/ml for Lea (5-HT, 3-HO) and 1-3 /xg/ml for Leb (7-SY, 9-HM) (Table I) , indicating a similar HAI activity to human salivas against anti-Lea or anti-Leb immune serum. The P-1 fractions before rechromatography yielded 0.84mg (5-HT), 0.85mg (3-HO), 0.3mg (7-SY), and 1.3mg from a liter of urine. The elution profiles of the finally rechromatographed P-l and P-l-A for A-nonsecretor (5-HT) and O-secretor (7-SY) are shown in Fig. 1 . The results of the gel filtration profiles demonstrate the Mr distribution of the Lewis-active substances before and after alkaline degradation, as also indicated in Table I . The results of the amino acid analysis are shown in Table II . Four samples of P-l contained Asp, Thr, Ser, Glu, Gly, Ala, and Val as the main composite amino acids. No amino acids were detectable in the P-l-A fraction (5-HT, 7-SY), except a minor peak of Asp (below 0.1%). Carbohydrate analysis revealed that both fractions P-l and P-l-A were substantially composed of fucose, mannose, galactose, and glucosamine (Table I) . No significant difference was recognized amongthe carbohydrate constituents of the isolated P-l fractions, except for fucose, a determinant sugar of the Lewis antigen.9) In Table I , variations in the gas chromatographic determination are considered to be within 10%. Galactosamine was marginally detected (below the determination limit) for P-l-A in each case. However, no peak corresponding to galactosamine was recognized in these P-l fractions. Fucose amounting 20~30%for secretors and 10 -20% for nonsecretors mayplay an important role in the blood group activity, as partly demonstrated by the fact10) that most of the fucose (70%) was liberated from the P-l fractions (5-HT, 7-SY) at 100°C for 60 min at pH 1.8 with complete loss of the Lewis activity. It may be difficult to obtain the homogeneous Lewis-active substance from urine which contains many heterogeneous complex carbohydrates as already reviewed.11} The urinary glycopeptides rich in fucose mostly do not concern blood group activity.12'13* Meanwhile, blood group A-and B-active substances have been isolated,14) but they were not homogeneous by ultracentrifugal analysis. The heterogeneous
Mr distribution of the blood group active substances in human urine may generally occur according to the individual metabolic or genetic regulation excreted from some unknown origin, as partially indicated in the previous paper.
3) The purified P-l fractions were mostly comprised of carbohydrates, and proteinous contaminant matters were effectively removed by gel filtration and adsorption chromatography on the Bio-Gel (P-6) column.5) The P-l fractions (5-HT, 7-SY) exhibited considerable homogeneity by ultracentrifugal analysis.10) The experimental results, as indicated in Table I , imply that the Mrof the Lewis-active substances in humanurine are generally distributed in the range of 10,000 ± 2000 without much difference between individuals. Mannose (5~10%), as shownin Table I , maybe the composite sugar of the Lewis-active substances in human urine, based on the following criteria: The purified fractions of P-l-A possessed a similar amount of mannosecompared to the amount in P-l, and further purification ofP-l-A (7-SY) on a Con A-Sepharose affinity column did not essentially affect the carbohydrate composition.15) The isolated Lewis-active substances (P-l) are considered as glycopeptides possessing a glycosidic linkage to 7V-acetylgalactosaminylserine (-threonine) from the results of the amino acid analysis and the alkali-catalyzed pelimination reaction. However, galactosaminitol in P-l-A was not sufficiently detected for clarifying the 'mucin type' linkage, and was probably decomposed by a 'peeling reaction'16) during the alkaline degradation.
It is further noteworthy to mention that the Mr (5000± 500) of P-l-A was much larger than the blood group active oligosaccharides cleaved by a^-elimination reaction isolated from the other biological sources, as recently reported.17>18)
